154 related articles for article (PubMed ID: 15861669)
1. [Self- and non-self recognition mechanism via the complement system].
Okada N
Nihon Rinsho; 2005 Apr; 63 Suppl 4():279-83. PubMed ID: 15861669
[No Abstract] [Full Text] [Related]
2. [Complement regulatory proteins].
Miyagawa S
Nihon Rinsho; 2005 Apr; 63 Suppl 4():274-8. PubMed ID: 15861668
[No Abstract] [Full Text] [Related]
3. The regulation of the complement system: insights from genetically-engineered mice.
Turnberg D; Botto M
Mol Immunol; 2003 Sep; 40(2-4):145-53. PubMed ID: 12914820
[TBL] [Abstract][Full Text] [Related]
4. Human regulator of complement activation (RCA) gene family proteins and their relationship to microbial infection.
Seya T
Microbiol Immunol; 1995; 39(5):295-305. PubMed ID: 7565169
[No Abstract] [Full Text] [Related]
5. Adenovirus-mediated gene transfer of the triple human complement regulating proteins (DAF, CD59, MCP) in xenogeneic pig liver perfusion.
Shiraishi M; Nagahama M; Nozato E; Oshiro T; Taira K; Muto Y
Transplant Proc; 2000 Aug; 32(5):1116-7. PubMed ID: 10936387
[No Abstract] [Full Text] [Related]
6. Immune evasion of tumor cells using membrane-bound complement regulatory proteins.
Gorter A; Meri S
Immunol Today; 1999 Dec; 20(12):576-82. PubMed ID: 10562709
[TBL] [Abstract][Full Text] [Related]
7. C5b-8 step lysis of swine endothelial cells by human complement and functional feature of transfected CD59.
Miyagawa S; Mikata S; Shirakura R; Matsuda H; Nagasawa S; Terados A; Hatanaka M; Matsumoto M; Seya T
Scand J Immunol; 1996 Apr; 43(4):361-6. PubMed ID: 8668913
[TBL] [Abstract][Full Text] [Related]
8. Membrane-associated proteins regulating the complement system: functions and deficiencies.
Schieren G; Hänsch GM
Int Rev Immunol; 1993; 10(1):87-101. PubMed ID: 7688019
[No Abstract] [Full Text] [Related]
9. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors.
Fishelson Z; Donin N; Zell S; Schultz S; Kirschfink M
Mol Immunol; 2003 Sep; 40(2-4):109-23. PubMed ID: 12914817
[TBL] [Abstract][Full Text] [Related]
10. Expression of complement inhibitors CD46, CD55, and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma.
Weng WK; Levy R
Blood; 2001 Sep; 98(5):1352-7. PubMed ID: 11520782
[TBL] [Abstract][Full Text] [Related]
11. Membrane complement regulatory proteins in autoimmune and inflammatory tissue injury.
Song WC
Curr Dir Autoimmun; 2004; 7():181-99. PubMed ID: 14719381
[TBL] [Abstract][Full Text] [Related]
12. Complement regulatory proteins on human and porcine nontransgenic and hDAF transgenic islet cells: expression and role in susceptibility to lysis by human serum.
Bennet W; Sundberg B; Elgue G; Brendel M; Richards A; White DJ; Groth C; Korsgren O
Transplant Proc; 2000 Aug; 32(5):1066. PubMed ID: 10936358
[No Abstract] [Full Text] [Related]
13. Complement regulation.
Meri S; Jarva H
Vox Sang; 1998; 74 Suppl 2():291-302. PubMed ID: 9704459
[TBL] [Abstract][Full Text] [Related]
14. Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition.
Mason JC; Yarwood H; Sugars K; Morgan BP; Davies KA; Haskard DO
Blood; 1999 Sep; 94(5):1673-82. PubMed ID: 10477692
[TBL] [Abstract][Full Text] [Related]
15. Human CD46 rather than CD55 is a key element in protection against complement activation in vitro.
van Dixhoorn MG; Dekker S; Janssen RW; Verbakel CA; Grosveld F
Transplant Proc; 2000 Aug; 32(5):916-8. PubMed ID: 10936272
[No Abstract] [Full Text] [Related]
16. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
Miwa T; Zhou L; Hilliard B; Molina H; Song WC
Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227
[TBL] [Abstract][Full Text] [Related]
17. Membrane-bound complement regulatory proteins inhibit complement activation by an immunotherapeutic mAb in a syngeneic rat colorectal cancer model.
Gelderman KA; Hakulinen J; Hagenaars M; Kuppen PJ; Meri S; Gorter A
Mol Immunol; 2003 Sep; 40(1):13-23. PubMed ID: 12909127
[TBL] [Abstract][Full Text] [Related]
18. The complement receptors CD46, CD55 and CD59 are regulated by the tumour microenvironment of head and neck cancer to facilitate escape of complement attack.
Kesselring R; Thiel A; Pries R; Fichtner-Feigl S; Brunner S; Seidel P; Bruchhage KL; Wollenberg B
Eur J Cancer; 2014 Aug; 50(12):2152-61. PubMed ID: 24915776
[TBL] [Abstract][Full Text] [Related]
19. Separation of self from non-self in the complement system: a role for membrane cofactor protein and decay accelerating factor.
Atkinson JP; Oglesby TJ; White D; Adams EA; Liszewski MK
Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):27-30. PubMed ID: 1718640
[No Abstract] [Full Text] [Related]
20. Anti-inflammatory and immunosuppressive effects of recombinant soluble complement receptors.
Fearon DT
Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):43-6. PubMed ID: 1718643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]